Cannabis has long been used to relieve pain, improve sleep, and lift brain fog. In recent years, researchers have focused on the potential benefits of cannabis for cancer patients.
Researchers at the University of Colorado at Boulder recently conducted a study recently to analyze how medicinal cannabis products, bought from dispensaries, can control cancer symptoms and manage the side effects of chemotherapy. The Exploration in Medicine journal report revealed that people with cancer who tried cannabis to alleviate symptoms experienced reduced pain, enhanced sleep quality, and heightened cognitive performance.
People battling cancer have been using marijuana as a way of dealing with the negative effects that come along with chemotherapy, including but not limited to pain, nausea, and insomnia. This use of cannabis is not something new as a research study conducted at the University of Colorado at Boulder was one of the first to look into the advantageous effects of cannabis products bought from dispensaries for cancer patients.
Twenty-five cancer patients were observed to measure the effects of cannabis purchased from dispensaries. Results showed that their pain levels decreased dramatically within 60 minutes of using the products. After using them for two weeks, people noticed an enhancement in their sleeping regimen as well as cognitive abilities.
Cannabis has two primary components, CBD and THC. CBD has anti-inflammatory properties that alleviate pain and help induce sleep. On the other hand, THC is the substance in cannabis that can produce a “high” feeling and disturb cognitive abilities.The research revealed that individuals who took higher dosages of CBD experienced noteworthy enhancements in sleep and pain.
The Potential of Cannabis for Cancer Treatment
According to a study conducted by the University of Colorado at Boulder, cannabis has the potential to be used as an additional therapy option for cancer patients who are struggling with pain or cognitive issues. Yet, this study was not without its drawbacks; for instance, the sample size was quite limited and it relied on self-reported information. To back up these findings, there is a need for more research on a larger, more varied population with research utilizing more objective measurements. Additionally, it is critical to examine any risks or negative side effects linked to cannabis usage in cancer patients.
The medical marijuana industry is on an upswing, with a market value estimated to hit $248 billion by 2030. Multiple initiatives in Congress could decriminalize or legalize marijuana, thus ushering in more research and data for medical practitioners.